The effect of targeted oxygen therapy on the recovery outcomes of Covid-19 patients

Determining the effect of targeted oxygen therapy on the recovery outcomes of Covid-19 patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211116053079N1

Enrollment

Registered

2022-05-10

Start date

2022-06-01

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. u07.1

Interventions

Intervention 1: Intervention group: In the intervention group, oxygen therapy is given in a targeted manner (spo2 = 92-93%) as a nasal catheter in the volume of 2-4 liters per minute and the blood oxy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with positive pcR Patients with mild lung involvement on CT scan Patients with spo2 Less than 92%

Exclusion criteria

Exclusion criteria: Failure to continue the intervention Patients who become ill during the project. Patients receiving ICU admission

Design outcomes

Primary

Measure	Time frame
SPo2. Timepoint: Upon arrival, 24 hours after, discharge. Method of measurement: Puls oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Ferdosib

Bagheiat-allah University of Medical Sciences

Ferdosim732@gmail.com+98 21 8126 7112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026